Test new drug-eluting stent with less blood thinner
Part of Heart & circulation clinical trials.
This study compares a new type of “drug-eluting” stent (a tiny scaffold that slowly releases medicine) and a single blood-thinner plan versus the usual two-drug blood thinner plan after stent placement in the left main coronary artery. It aims to see if the simpler plan can work while keeping the stent safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older.
- You have recent or ongoing heart chest pain from blocked heart arteries (unstable angina or non–ST-elevation acute coronary syndrome).
- You’re having (or just had) a successful stent procedure in the “left main” artery that is not covered by a previous stent, using this specific ultrathin drug-eluting stent.
- You can read and sign the consent form before the procedure.
- You must be able and willing to follow a prescribed blood-thinner plan for at least 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a drug-coated balloon alongside a stent improves outcomes for people with a blockage in the left main coronary artery, the main artery supplying the heart. It compares this approach to standard stenting, aiming to reduce re-blockage risk.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
Hear when a new Left Main Coronary Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.